Neuren Pharmaceuticals | NEU - Current Assets


Neuren Pharmaceuticals reported AUD332.23M in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 35.49M 760K Dec/2025
Clinuvel Pharmaceuticals AUD 261.38M 1.59M Dec/2025
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Genetic Signatures AUD 42.96M 5.02M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
Medical Developments International AUD 33.75M 1.79M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Paradigm Biopharmaceuticals AUD 21.67M 2.46M Dec/2025
PYC Therapeutics AUD 153.74M 23.79M Dec/2025
Starpharma Holdings AUD 24.24M 1.68M Dec/2025
Tectonic Therapeutic USD 257.36M 15.88M Dec/2025
Telix Pharmaceuticals AUD 330.28M 67.73M Dec/2025
Viatris USD 9.79B 162.2M Dec/2025
Xeris Pharmaceuticals USD 240.31M 16.3M Dec/2025